Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure.

作者: Wilbert S. Aronow

DOI: 10.1097/01.CRD.0000175289.87583.E5

关键词: Heart failureDigoxinEjection fractionACE inhibitorCardiologyIsosorbide dinitrateSystoleDiastoleInternal medicineDiastolic heart failureMedicine

摘要: Underlying causes, risk factors, and precipitating causes of heart failure (HF) should be treated. Drugs known to precipitate or aggravate HF such as nonsteroidal antiinflammatory drugs stopped. Patients with a low left ventricular ejection fraction (systolic failure) normal (diastolic HF) treated diuretics if fluid retention is present, an angiotensin-converting enzyme (ACE) inhibitor angiotensin receptor blocker the patient cannot tolerate ACE because cough, angioneurotic edema, rash, altered taste sensation, beta unless contraindicated. If severe systolic persists, aldosterone antagonist added. isosorbide dinitrate plus hydralazine Calcium channel blockers avoided present. Digoxin in men women diastolic sinus rhythm present HF. given symptoms persist, but serum digoxin level maintained between 0.5 0.8 ng/mL.

参考文章(172)
R. Hachamovitch, P. Wicker, J. M. Capasso, P. Anversa, Alterations of coronary blood flow and reserve with aging in Fischer 344 rats. American Journal of Physiology-heart and Circulatory Physiology. ,vol. 256, ,(1989) , 10.1152/AJPHEART.1989.256.1.H66
E. G. Lakatta, F. C. Yin, Myocardial aging: functional alterations and related cellular mechanisms American Journal of Physiology-heart and Circulatory Physiology. ,vol. 242, ,(1982) , 10.1152/AJPHEART.1982.242.6.H927
Rekha Garg, Salim Yusuf, WD Bussmann, Peter Sleight, Andrew Uprichard, Barry Massie, Barry McGrath, Berit Nilsson, Bertram Pitt, Bruno Magnani, Carol Maskin, Ettore Ambrosioni, Ewa Rucinska, Franz X Kleber, Gary Jennings, Gianni Tognoni, Helmut Drexler, John GF Cleland, Joseph A Franciosa, Jouko Remes, Karl Swedberg, Kenneth Dickstein, Lothar Maass, Marc Pfeffer, Mark A Creager, Maryann Gordon, Michael Joy, Norman Sharpe, Pierre Desche, Robin McGarry, Rory Collins, Steven G Chrysant, Vincenzo Cicchetti, Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure JAMA: The Journal of the American Medical Association. ,vol. 273, pp. 1450- 1456 ,(1995) , 10.1001/JAMA.1995.03520420066040
Ramachandran S Vasan, Martin G Larson, ScD, Emelia J Benjamin, Jane C Evans, Craig K Reiss, Daniel Levy, Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. Journal of the American College of Cardiology. ,vol. 33, pp. 1948- 1955 ,(1999) , 10.1016/S0735-1097(99)00118-7
Pascal Vantrimpont, Jean L Rouleau, Chuan-Chuan Wun, Antonio Ciampi, Marc Klein, Bruce Sussex, J Malcolm O Arnold, Lemuel Moyé, Marc Pfeffer, SAVE Investigators 1 ABCDEF, None, Additive Beneficial Effects of Beta-Blockers to Angiotensin-Converting Enzyme Inhibitors in the Survival and Ventricular Enlargement (SAVE) Study Journal of the American College of Cardiology. ,vol. 29, pp. 229- 236 ,(1997) , 10.1016/S0735-1097(96)00489-5